Physician profile
Jason C Goodwin
NPI 1972737237
$1,527.35
in general payments reported to CMS, 2019-2025
16 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2022: $129 · 2023: $306 · 2024: $630 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,214.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $454.19 | 2023-2025 | Inspire |
| Regeneron Healthcare Solutions, INC. | $413.12 | 2022-2025 | Dupixent |
| Genzyme Corporation | $178.68 | 2023-2024 | |
| Stryker Corporation | $124.11 | 2019 | |
| Glaxosmithkline, LLC. | $73.53 | 2022-2025 | Nucala |
| Medtronic, INC. | $42.45 | 2024-2025 | Propel |
| Intersect Ent, INC. | $41.80 | 2019 | |
| Boston Scientific Corporation | $41.35 | 2024 | Advantage System |
| Cochlear Americas | $33.62 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
| Genentech USA, INC. | $22.26 | 2022 | |
| Aerin Medical INC. | $20.78 | 2024 | |
| Optinose US, INC. | $18.37 | 2022 | |
| Abbott Laboratories | $17.73 | 2019 | |
| Hikma Pharmaceuticals USA | $17.60 | 2024 | Ryaltris |
| Electromed, INC. | $15.50 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $12.26 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Goodwin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.